B+
Bull case
25%
Probability
Target price
$9.73
-90.4% vs current
Market tone is neutral-to-cautious: investors focus on occupancy and reimbursement signals ahead of earnings. Newsflow (earnings, policy) drives episodic volatility rather than sustained conviction.
No evidence quality warning is currently attached to this memo.
Quarterly results or guidance that update inpatient rehab occupancy, payer mix and margin trajectory; primary event for near-term re-pricing [#10-Q-2025].
Regional referral shifts, capacity changes, or M&A announcements that change growth profile or near-term cash flow visibility [#PR-2025-06].
CMS or payer rule changes that alter payment rates or interpretations for post-acute care, materially impacting revenue per case and margins [#CMS].
No formal recommendation provided.